European Archives - Page 212 of 1214 - European Medical Journal

New Assessment Scheme Improves Tumour Segmentation in Glioblastoma Imaging

A new assessment scheme highlights the strengths and limitations of automatic tumour segmentation tools for glioblastoma on MRI.

Procalcitonin Guidance Fails to Shorten Antibiotic Use in Children

Using a procalcitonin-guided algorithm does not significantly reduce duration of IV antibiotic treatment in children with bacterial infections.

Genetic Mechanisms Driving Age-Related Clonal Haematopoiesis

Recent research has uncovered key insights into the genetic mechanisms driving age-related clonal haematopoiesis…

Combination Therapy Improves Androgenic Alopecia Outcomes

Combining fractional CO2 laser with topical dutasteride improves androgenic alopecia outcomes compared to laser treatment alone.

Novel Drug Pair Tackles Antibody-Mediated Kidney Transplant Rejection

A new therapy combining daratumumab and tocilizumab offers hope for kidney transplant patients battling late antibody-mediated rejection.

Aspirin-Free Antithrombotic Strategy Proven Safe for Advanced Heart Failure

Aspirin avoidance in patients with HeartMate 3 LVAD reduces bleeding risk without increasing thrombosis, even with vascular conditions.

New Non-Invasive Diagnostic Tool for Primary Sjögren’s Disease

A new diagnostic model combining salivary biomarkers and serum tests offers a non-invasive, highly accurate method to detect primary Sjögren’s disease.

Biodegradable Electrodes Stimulate Brain Repair for Neurological Disorders

Flexible, biodegradable electrodes stimulate brain repair, offering safe, temporary treatment for neurological disorders, revolutionising patient care.

Digital Tools Enhance Genetic Testing for Hereditary Cancer Risk

A recent study has demonstrated the effectiveness of online screening and virtual patient education tools in improving hereditary cancer risk assessments

Prostate Cancer Recurrence Risk with Testosterone Therapy

These findings suggest that testosterone therapy can be safely administered to carefully selected men following radical prostatectomy without increasing the risk of biochemical recurrence.